GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | STAT3 | decreases expression | EXP | | 6480464 | CTD | Erlotinib Hydrochloride results in decreased expression of STAT3 protein modified form | PMID:30136359 | STAT3 | decreases response to substance | EXP | | 6480464 | CTD | STAT3 mRNA results in decreased susceptibility to Erlotinib Hydrochloride | PMID:23125191 | STAT3 | increases phosphorylation | EXP | | 6480464 | CTD | Erlotinib Hydrochloride results in increased phosphorylation of STAT3 protein | PMID:23894143 | STAT3 | increases response to substance | EXP | | 6480464 | CTD | STAT3 mutant form results in increased susceptibility to Erlotinib Hydrochloride | PMID:23894143 | STAT3 | multiple interactions | EXP | | 6480464 | CTD | [Betulinic Acid co-treated with Erlotinib Hydrochloride] results in decreased expression of STAT3 protein modified form; [Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased phosphorylation of STAT3 protein]] which results in increased susceptibility to Erlotinib Hydrochloride; Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased phosphorylation of STAT3 protein] | PMID:23894143 PMID:30136359 | |
Go Back to source page | Continue to Ontology report |